(Q38176985)

30 August 2017

title

Clinical implications of body composition assessment by computed tomography in metastatic renal cell carcinoma (English)

1 reference

30 August 2017

1 reference

2

Emilie Lanoy

0 references

Laurence Albiges

3

object named as

Laurence Albiges-Sauvin

0 references

Bernard Escudier

4

object named as

Bernard Escudier

1 reference

30 August 2017

Sami Antoun

1

1 reference

30 August 2017

Emilie Lanoy

2

1 reference

30 August 2017

Laurence Albiges-Sauvin

3

1 reference

30 August 2017

publication date

9 January 2014

1 reference

Expert Review of Anticancer Therapy

30 August 2017

published in

1 reference

30 August 2017

volume

14

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

279-288

1 reference

describes a project that uses

30 August 2017

1 reference

Rising incidence of renal cell cancer in the United States

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Difficulty in predicting survival in metastatic renal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Risk factor paradox in wasting diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Dual-energy X-ray absorptiometry and body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Human body composition: advances in models and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Sarcopenia as a prognostic factor among patients with stage III melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

The growing challenge of obesity and cancer: an inflammatory issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Do muscle mass, muscle density, strength, and physical function similarly influence risk of hospitalization in older adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Clustering of strength, physical function, muscle, and adiposity characteristics and risk of disability in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Impact of body composition on clinical outcomes in metastatic renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

An activated mTOR mutant supports growth factor-independent, nutrient-dependent cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Waste management - cytokines, growth factors and cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Inflammatory burden and amino acid metabolism in cancer cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.866040

10.1586/14737140.2013.866040

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference